We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.9B
AUM Growth
+$1.63B
Cap. Flow
-$1.42B
Cap. Flow %
-4.19%
Top 10 Hldgs %
15.42%
Holding
3,077
New
93
Increased
384
Reduced
2,402
Closed
59

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.6M
2
XOM icon
ExxonMobil
XOM
+$33.5M
3
DELL
DELL INC
DELL
+$27.8M
4
GE icon
GE Aerospace
GE
+$22.8M
5
IBM icon
IBM
IBM
+$19M

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Technology 13.93%
3 Healthcare 12.71%
4 Industrials 11.47%
5 Energy 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTCH
2951
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$104K ﹤0.01%
32,365
-2,400
-7% -$7.88K
NEO icon
2952
NeoGenomics
NEO
$2.04B
$103K ﹤0.01%
28,477
ULTR
2953
DELISTED
ULTRAPETROL (BAHAMAS) LTD COM STK
ULTR
$103K ﹤0.01%
27,514
-1,900
-6% -$6.75K
GCAP
2954
DELISTED
Gain Capital Holdings, Inc.
GCAP
$100K ﹤0.01%
13,312
-1,000
-7% -$10.1K
GMO
2955
DELISTED
General Moly, Inc.
GMO
$99K ﹤0.01%
73,996
-5,300
-7% -$7.61K
SUPN icon
2956
Supernus Pharmaceuticals
SUPN
$2.67B
$97K ﹤0.01%
12,862
GGB icon
2957
Gerdau
GGB
$9.93B
$96K ﹤0.01%
+15,372
New +$96K
INTX
2958
DELISTED
Intersections, Inc.
INTX
$95K ﹤0.01%
12,234
-850
-6% -$7.07K
SKH
2959
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
$95K ﹤0.01%
19,848
-3,500
-15% -$16.3K
LCTX icon
2960
Lineage Cell Therapeutics
LCTX
$277M
$94K ﹤0.01%
32,322
PCYO icon
2961
Pure Cycle
PCYO
$258M
$93K ﹤0.01%
14,759
LOV
2962
DELISTED
Spark Networks SE American Depositary Shares
LOV
$93K ﹤0.01%
15,101
DWSN icon
2963
Dawson Geophysical
DWSN
$145M
$92K ﹤0.01%
4,433
-861
-16% -$17.9K
STRP
2964
DELISTED
Straight Path Communications Inc.
STRP
$92K ﹤0.01%
11,260
-78
-0.7% -$511
APP
2965
DELISTED
AMERICAN APPAREL INC COM
APP
$91K ﹤0.01%
73,605
-5,100
-6% -$6.05K
NSPH
2966
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$90K ﹤0.01%
1,957
+50
+3% +$2.09K
RVLT
2967
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$90K ﹤0.01%
2,616
-520
-17% -$17.1K
ISSC icon
2968
Innovative Solutions & Support
ISSC
$348M
$89K ﹤0.01%
12,176
FMD
2969
DELISTED
FIRST MARBLEHEAD CORP COM STK NEW (DE)
FMD
$89K ﹤0.01%
11,976
-850
-7% -$6.88K
ENPH icon
2970
Enphase Energy
ENPH
$5.2B
$88K ﹤0.01%
13,923
HNRG icon
2971
Hallador Energy
HNRG
$704M
$88K ﹤0.01%
10,924
-800
-7% -$5.95K
VSB
2972
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$85K ﹤0.01%
16,099
-1,100
-6% -$5.67K
BODY
2973
DELISTED
BODY CENTRAL CORP COM STK
BODY
$84K ﹤0.01%
21,272
-1,500
-7% -$6.5K
MDW
2974
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$83K ﹤0.01%
102,557
BIOL
2975
DELISTED
Biolase, Inc.
BIOL
$82K ﹤0.01%
2
-1
-33% -$23.7K

Similar funds

RhumbLine Advisers's Q4 2013 Portfolio in Review

As of Q4 2013, RhumbLine Advisers held 3,077 positions worth $33.9B, up 5% from $32.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.42B in Q4 2013, closing 59 positions and reducing 2,402 holdings. Its most notable exit was NYSE EURONEXT INC, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Transocean worth $12.5M.

  • RhumbLine Advisers's largest Q4 2013 buy was Transocean: 252,714 shares worth $12.5M.
  • RhumbLine Advisers added most to Meta Platforms (Facebook) in Q4 2013, an estimated $50.1M increase.
  • RhumbLine Advisers's biggest Q4 2013 reduction was Apple, cutting an estimated $41.6M.
  • RhumbLine Advisers fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $15.2M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.9B portfolio in Q4 2013.
  • RhumbLine Advisers opened 93 new positions and closed 59 in Q4 2013.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $33.9B.

Based on RhumbLine Advisers's 13F filing for Q4 2013, filed 3 Feb 2014.